182 related articles for article (PubMed ID: 25526566)
1. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation.
Li K; Yang J; Han X
Int J Mol Sci; 2014 Dec; 15(12):23519-36. PubMed ID: 25526566
[TBL] [Abstract][Full Text] [Related]
2. Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin
Chen D; Yan Y; Xie J; Pan J; Chen Y; Li Q; Yuan Y; Zeng W; Xing W
J Cancer; 2020; 11(24):7312-7319. PubMed ID: 33193895
[No Abstract] [Full Text] [Related]
3. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.
Lirk P; Berger R; Hollmann MW; Fiegl H
Br J Anaesth; 2012 Aug; 109(2):200-7. PubMed ID: 22542536
[TBL] [Abstract][Full Text] [Related]
4. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Zhao QZ; Dou KF
J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
6. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin.
Domínguez-Gómez G; Díaz-Chávez J; Chávez-Blanco A; Gonzalez-Fierro A; Jiménez-Salazar JE; Damián-Matsumura P; Gómez-Quiroz LE; Dueñas-González A
Oncol Rep; 2015 Feb; 33(2):721-8. PubMed ID: 25504347
[TBL] [Abstract][Full Text] [Related]
9. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
10. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
[TBL] [Abstract][Full Text] [Related]
11. 5-Aza-2'-Deoxycytidine and CDDP Synergistically Induce Apoptosis in Renal Carcinoma Cells via Enhancing the APAF-1 Activity.
Zhu X; Yi F; Chen P; Chen L; Zhang X; Cao C; Tan W
Clin Lab; 2015; 61(12):1821-30. PubMed ID: 26882803
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro.
Lirk P; Hollmann MW; Fleischer M; Weber NC; Fiegl H
Br J Anaesth; 2014 Jul; 113 Suppl 1():i32-8. PubMed ID: 24946779
[TBL] [Abstract][Full Text] [Related]
14. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
Liu Y; Zhou J; Hu Y; Wang J; Yuan C
Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
Wallden B; Emond M; Swift ME; Disis ML; Swisshelm K
BMC Cancer; 2005 Oct; 5():140. PubMed ID: 16255778
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms.
Sigurðsson HH; Olesen CW; Dybboe R; Lauritzen G; Pedersen SF
Mol Cancer Res; 2015 Jan; 13(1):63-77. PubMed ID: 25143433
[TBL] [Abstract][Full Text] [Related]
18. Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer.
Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Fabianowska-Majewska K
Biochem Biophys Res Commun; 2013 Jan; 430(2):623-8. PubMed ID: 23219837
[TBL] [Abstract][Full Text] [Related]
19. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.
Wang S; Dorsey TH; Terunuma A; Kittles RA; Ambs S; Kwabi-Addo B
PLoS One; 2012; 7(5):e37928. PubMed ID: 22701537
[TBL] [Abstract][Full Text] [Related]
20. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
